Talius Group Limited is pleased to announce the appointment of Dr. Maggie Haertsch to its Board of Directors as an Executive Director, effective immediately.
Dr. Haertsch, a seasoned expert in the aged care industry, has been with Talius since March 2023, serving as the Consulting Clinical Research Director. During her tenure, she has been instrumental in advancing Talius’ strategic initiatives, including forging alliances with industry bodies, successfully managing the ARIIA Grant project, and refining the Company’s strategy across the residential aged care and home care sectors.
In her new role, Dr. Haertsch will continue to report to Managing Director Graham Russell while expanding her responsibilities within the Board.
With over 40 years of experience in the health and aged care sectors, both in Australia and internationally, Dr. Haertsch brings a wealth of knowledge and a diverse skill set to the Talius Board. Her extensive career spans clinical practice in tertiary teaching hospitals, acute care services, community settings, and low-tech environments, complemented by significant leadership roles in research, education, and executive management.
Dr. Haertsch is exceptionally qualified to contribute to Talius’ mission in the aged care sector. She holds a PhD in Behavioral Sciences in Medicine, has completed the Leadership in Digital Transformation in Healthcare program at Harvard Medical School, and possesses a Post-Graduate Diploma in Health Science (Primary Health Care) from the Faculty of Health Sciences from the University of Newcastle. In addition, she is a Registered Nurse and was previously a Registered Midwife.
Commenting on Dr. Haertsch’s appointment, Mr. Graham Russell, Managing Director said:
“We are delighted to welcome Dr. Maggie Haertsch to the Board of Directors. Over the past year, Maggie has been a vital part of our senior management team, offering her expertise as a consultant and industry leader. Her contributions have been pivotal in sharpening our focus on the aged care sector, and she will continue to play a key role in client engagement and internal governance, benefiting both our clients and shareholders.”